The relationship between glycemic control and plasma vascular endothelial growth factor and endothelin-1 concentration in diabetic patients-Reference-Cited by-同舟云学术

The relationship between glycemic control and plasma vascular endothelial growth factor and endothelin-1 concentration in diabetic patients

Published:2004-05 Issue:5 Volume:53 Page:550-555
ISSN:0026-0495
Container-title:Metabolism
language:en
Short-container-title:Metabolism

Author:

Kakizawa Hiroaki,Itoh Mitsuyasu,Itoh Yasutoshi,Imamura Shigeo,Ishiwata Yoko,Matsumoto Takashi,Yamamoto Keiko,Kato Taiya,Ono Yasunaga,Nagata Mutsuko,Hayakawa Nobuki,Suzuki Atsushi,Goto Yoshie,Oda Naohisa

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference35 articles.

1. Prevention strategies for type 2 diabetes mellitus—A health and economic perspective;Eastman,2000

2. Endothelin;Hopfner;Diabetologia,1999

3. Role of vascular endothelial growth factor in diabetic vascular complications;Aiello;Kidney Int,2000

4. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes;Br Med J,1998

5. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells;Ferrara;Biochem Biophys Res Commun,1989

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neurological dysfunction screening in a cohort of adolescents with type 1 diabetes: a six-year follow-up;Frontiers in Medicine;2024-05-09

2. Serum VEGF as a predictive marker of glycemic control and diabetic nephropathy in Chinese older adults with type 2 diabetes mellitus;Frontiers in Endocrinology;2023-11-22

3. Diet-induced obesity results in endothelial cell desensitization to VEGF-A and permanent islet vascular dysfunction;2023-11-08

4. Endothelin receptor antagonism improves glucose tolerance and adipose tissue inflammation in an experimental model of systemic lupus erythematosus;American Journal of Physiology-Endocrinology and Metabolism;2023-01-01

5. Big Endothelin-1 and long-term all-cause death in patients with coronary artery disease and prediabetes or diabetes after percutaneous coronary intervention;Nutrition, Metabolism and Cardiovascular Diseases;2022-09